Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GTX Inc (NASDAQ:GTXI)

0.60
Delayed Data
As of Aug 30
 +0.016 / +2.74%
Today’s Change
0.29
Today|||52-Week Range
1.20
-14.29%
Year-to-Date
No recent news for GTX Inc.

Today’s Trading

Previous close0.58
Today’s open0.58
Day’s range0.58 - 0.60
Volume11,439
Average volume (3 months)62,508
Market cap$82.9M
Dividend yield--
Data as of 4:00pm ET, 08/30/2016

Growth & Valuation

Earnings growth (last year)+68.75%
Earnings growth (this year)+20.00%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)--
P/E ratio3.3
Price/Sales--
Price/Book44.11

Competitors

 Today’s
change
Today’s
% change
ZYNEZynerba Pharmaceutic...-0.01-0.11%
CEMIChembio Diagnostics ...+0.36+5.25%
NAVBNavidea Biopharmaceu...-0.00-0.56%
--Innovative Pharmaceu...0.000.00%
Data as of 4:02pm ET, 08/30/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$18.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Class I Director
Marc Steven Hanover
Principal Financial &
Accounting Officer
Jason T. Shackelford
Corporate headquarters
Memphis, Tennessee

Forecasts

Search for Jobs